Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Ribavirin 200mg capsule+interferon alpha-2b 3million iu/vial injection solution |
Is a |
Ribavirin+interferon alpha-2b |
false |
Inferred relationship |
Some |
|
|
Ribavirin 200mg capsule+interferon alpha-2b 3million iu/vial injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Cytokine |
false |
Inferred relationship |
Some |
|
|
Ribavirin 200mg capsule+interferon alpha-2b 3million iu/vial injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Interferon alfa-2b |
false |
Inferred relationship |
Some |
|
|
Ribavirin 200mg capsule+interferon alpha-2b 3million iu/vial injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Interferon alfa |
false |
Inferred relationship |
Some |
|
|
Ribavirin 200mg capsule+interferon alpha-2b 3million iu/vial injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Ribavirin (substance) |
false |
Inferred relationship |
Some |
|
|
Ribavirin 200mg capsule+interferon alpha-2b 3million iu/vial injection solution |
Has manufactured dose form |
injection |
false |
Inferred relationship |
Some |
|
|
Ribavirin 200mg capsule+interferon alpha-2b 3million iu/vial injection solution |
Has manufactured dose form |
Oral capsule |
false |
Inferred relationship |
Some |
|
|
Ribavirin 200mg capsule+interferon alpha-2b 3million iu/vial injection solution |
Is a |
Product manufactured as parenteral dose form (product) |
false |
Inferred relationship |
Some |
|
|
Ribavirin 200mg capsule+interferon alpha-2b 3million iu/vial injection solution |
Is a |
Ribavirin-containing product in oral dose form |
false |
Inferred relationship |
Some |
|
|
Ribavirin 200mg capsule+interferon alpha-2b 3million iu/vial injection solution |
Is a |
Ribavirin-containing product in parenteral dose form |
false |
Inferred relationship |
Some |
|
|